These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 15711854)

  • 1. Regional selectivity of amyloid mRNA expression and neurotrophins on repetitive inhibition of oxidative phosphorylation.
    von Arnim CA; Hellweg R; Büchner M; Huber R; Riepe MW
    J Neural Transm (Vienna); 2005 Apr; 112(4):491-8. PubMed ID: 15711854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer's disease.
    Iulita MF; Bistué Millón MB; Pentz R; Aguilar LF; Do Carmo S; Allard S; Michalski B; Wilson EN; Ducatenzeiler A; Bruno MA; Fahnestock M; Cuello AC
    Neurobiol Dis; 2017 Dec; 108():307-323. PubMed ID: 28865749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection and neuronal dysfunction upon repetitive inhibition of oxidative phosphorylation.
    Hellweg R; von Arnim CA; Büchner M; Huber R; Riepe MW
    Exp Neurol; 2003 Oct; 183(2):346-54. PubMed ID: 14552876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased pro-nerve growth factor and decreased brain-derived neurotrophic factor in non-Alzheimer's disease tauopathies.
    Belrose JC; Masoudi R; Michalski B; Fahnestock M
    Neurobiol Aging; 2014 Apr; 35(4):926-33. PubMed ID: 24112788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hAPP-YAC transgenic model has elevated UPS activity in the frontal cortex similar to Alzheimer's disease and Down's syndrome.
    Seo H; Isacson O
    J Neurochem; 2010 Sep; 114(6):1819-26. PubMed ID: 20698932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependent time course of cerebral brain-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 in APP23 transgenic mice.
    Schulte-Herbrüggen O; Eckart S; Deicke U; Kühl A; Otten U; Danker-Hopfe H; Abramowski D; Staufenbiel M; Hellweg R
    J Neurosci Res; 2008 Sep; 86(12):2774-83. PubMed ID: 18438945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene.
    Wang PL; Niidome T; Akaike A; Kihara T; Sugimoto H
    J Neurosci Res; 2009 Jul; 87(9):2105-14. PubMed ID: 19267423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotrophins and dementia--keeping in touch.
    Castrén E; Tanila H
    Neuron; 2006 Jul; 51(1):1-3. PubMed ID: 16815323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease.
    Botella-López A; Cuchillo-Ibáñez I; Cotrufo T; Mok SS; Li QX; Barquero MS; Dierssen M; Soriano E; Sáez-Valero J
    Neurobiol Dis; 2010 Mar; 37(3):682-91. PubMed ID: 20025970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial navigation in complex and radial mazes in APP23 animals and neurotrophin signaling as a biological marker of early impairment.
    Hellweg R; Lohmann P; Huber R; Kühl A; Riepe MW
    Learn Mem; 2006; 13(1):63-71. PubMed ID: 16418433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease.
    Wolf SA; Kronenberg G; Lehmann K; Blankenship A; Overall R; Staufenbiel M; Kempermann G
    Biol Psychiatry; 2006 Dec; 60(12):1314-23. PubMed ID: 16806094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Amyloid precursor protein and tau protein levels are differently regulated in human cerebellum compared to brain regions vulnerable to Alzheimer's type neurodegeneration.
    Caušević M; Farooq U; Lovestone S; Killick R
    Neurosci Lett; 2010 Nov; 485(3):162-6. PubMed ID: 20826196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of semax and its C-end peptide PGP on expression of the neurotrophins and their receptors in the rat brain during incomplete global ischemia].
    Stavchanskiĭ VV; Tvorogova TV; Botsina AIu; Skvortsova VI; Limborskaia SA; Miasoedov NF; Dergunova LV
    Mol Biol (Mosk); 2011; 45(6):1026-35. PubMed ID: 22295573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA-Seq analysis of frontal cortex and cerebellum from 5XFAD mice at early stage of disease pathology.
    Kim KH; Moon M; Yu SB; Mook-Jung I; Kim JI
    J Alzheimers Dis; 2012; 29(4):793-808. PubMed ID: 22507954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine effects on the regulation of amyloid precursor protein splicing, neurotrophin and glucose transporter RNA levels in aged rats.
    Monteggia LM; Arneric SP; Giordano T
    Int J Dev Neurosci; 1994 Apr; 12(2):133-41. PubMed ID: 7942088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of hypoxic tolerance in presymptomatic APP23 transgenic mice.
    von Arnim CA; Verstege E; Etrich SM; Riepe MW
    Mech Ageing Dev; 2006 Feb; 127(2):109-14. PubMed ID: 16274726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.
    Vaisid T; Kosower NS; Katzav A; Chapman J; Barnoy S
    Neurochem Int; 2007; 51(6-7):391-7. PubMed ID: 17513017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomic effects of depleted uranium on acetylcholine and cholesterol metabolisms in Alzheimer's disease model.
    Lestaevel P; Bensoussan H; Racine R; Airault F; Gourmelon P; Souidi M
    C R Biol; 2011 Feb; 334(2):85-90. PubMed ID: 21333939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of the Kv3.4 potassium channel subunit in early stages of Alzheimer's disease.
    Angulo E; Noé V; Casadó V; Mallol J; Gomez-Isla T; Lluis C; Ferrer I; Ciudad CJ; Franco R
    J Neurochem; 2004 Nov; 91(3):547-57. PubMed ID: 15485486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.